What is an aztreonam Drug Master File (DMF)?
A Drug Master File (DMF) is a regulatory filing submitted to the FDA that contains detailed information about a drug substance, drug product, or related manufacturing processes. An “aztreonam DMF” means a DMF specifically covering aztreonam (the active ingredient) and/or how it is produced and controlled for use in other companies’ FDA applications.
Who files the aztreonam DMF, and who uses it?
A DMF is typically held by the aztreonam manufacturer or a specialized supplier. Other companies (for example, generic or branded drug applicants) may reference that DMF in their own submissions (such as an ANDA for a generic drug) so they do not need to duplicate all the detailed chemistry/manufacturing/control information in their own application.
What kinds of aztreonam DMFs exist (and how to tell which you need)?
DMFs can cover different “types” (drug substance vs. sterilization/manufacturing steps for a drug product, depending on FDA DMF category). The key is whether the DMF is intended to support:
- The aztreonam active substance manufacturing/controls (so it supports the drug substance portion of an application), or
- A specific processing step that relates to the final drug product (if the referenced DMF covers manufacturing of the formulated/finished product aspect).
How do aztreonam DMFs relate to marketed products?
Aztreonam products (commonly used as an injectable antibiotic) are applications that must have manufacturing and control information for the drug substance and finished product. If a supplier’s aztreonam DMF is referenced, the applicant’s regulatory package relies on that DMF for the underlying detailed manufacturing and quality documentation.
Can you buy aztreonam if you have a DMF?
A DMF itself is not a product you buy; it’s a regulatory document. Access to a DMF’s contents generally requires the DMF holder’s permission, and the referencing is done within an FDA application framework.
Does DrugPatentWatch.com track aztreonam DMFs or DMF holders?
DrugPatentWatch.com is focused on patents and exclusivity rather than FDA DMFs. If you’re researching who holds patent or market exclusivity for aztreonam, DrugPatentWatch.com can help, but it would not replace DMF-specific FDA records.
If you’re trying to find the exact aztreonam DMF on file, what search terms work?
The most reliable approach is to search FDA systems for:
- “aztreonam” plus “DMF”
- The DMF holder’s company name
- If you know it, the DMF number (once identified, you can search it directly)
- Applicant/product context (for example, the final dosage form and NDA/ANDA name) to see which DMF gets referenced
If you tell me whether you mean “aztreonam DMF for drug substance” or “DMF for a specific aztreonam product/dosage form,” and (if you have it) the intended NDA/ANDA, I can narrow the likely DMF type you’re looking for and the most relevant way to locate it.
Sources
- [1] https://www.drugpatentwatch.com/